In the BioHarmony Drug Report Database

"Preview" Icon

Iloprost

Ventavis (iloprost) is a small molecule pharmaceutical. Iloprost was first approved as Ventavis on 2003-09-15. It is used to treat pulmonary hypertension in the USA. It has been approved in Europe to treat pulmonary hypertension. The pharmaceutical is active against prostacyclin receptor. In addition, it is known to target prostaglandin E2 receptor EP4 subtype, prostaglandin E2 receptor EP2 subtype, prostaglandin E2 receptor EP3 subtype, prostaglandin D2 receptor, thromboxane A2 receptor, prostaglandin F2-alpha receptor, and prostaglandin E2 receptor EP1 subtype.

 

Trade Name

 

Ventavis
 

Common Name

 

iloprost
 

ChEMBL ID

 

CHEMBL494
 

Indication

 

pulmonary hypertension
 

Drug Class

 

Prostaglandins

Image (chem structure or protein)

Iloprost structure rendering